Page last updated: 2024-10-25

cimetidine and Familial Combined Hyperlipidemia

cimetidine has been researched along with Familial Combined Hyperlipidemia in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research Excerpts

ExcerptRelevanceReference
"A 35-yr-old man with moderate hypertriglyceridemia, associated with a positive family history for hyperlipidemia, developed chylomicronemia with abdominal pain, muscle pain, and splenomegaly while being treated with cimetidine for a duodenal ulcer."3.67Chylomicronemia induced by cimetidine. ( Brunzell, JD; Iverius, PH, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iverius, PH1
Brunzell, JD1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia[NCT00005313]450 participants (Actual)Observational2001-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for cimetidine and Familial Combined Hyperlipidemia

ArticleYear
Chylomicronemia induced by cimetidine.
    Gastroenterology, 1985, Volume: 89, Issue:3

    Topics: Adult; Cholesterol; Chylomicrons; Cimetidine; Duodenal Ulcer; Humans; Hyperlipidemia, Familial Combi

1985